Abstract
The acute-phase protein, haptoglobin, is elevated in many diseases; however, its glycosylation also changes, and the type of change observed can vary with disease. Increased fucosylation is a common finding, and the fucose-specific lectin, lotus tetragonolobus, can be used to differentiate different diseases (eg inflammatory conditions, liver diseases), and to monitor disease activity in cancer. Changes in N-acetyl neuraminic acid and N-acetylglu-cosamine suggest that particular carbohydrate structures predominate in certain diseases. Because haptoglobin glycosylation provides a record of previous intracellular events, it will help to improve our understanding of pathological processes and provide potential clinical markers for the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dobryszycka W., 1993, Haptoglobin: retrospectives and perspectives, In: Mackiewicz A., Kushner, I., and Baumann H., eds. Acute phase proteins: molecular biology, biochemistry, and clinical applications, Boca Raton: CRC Press, 185–206.
Thompson, S., and Turner, O.A., 1987, Elevated levels of abnormally-fucosylated haptoglobins in cancer sera, Br.J.Cancer 56:605–610.
Katnik,I., Greber,J., and Dobryszycka,W., 1987, Affino-imniunoelectrophoresis of haptoglobin with wheat germ agglutinin. Diagnostic significance in ovarian cancer, Afch.Immunol.Therap.Exp. 35:547–551.
Thompson,S., Kelly,C.A., Griffiths,I.D. and Turner G.A., 1989, Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease, Clin.Chim.Acta 184:251–258.
Thompson,S., Cantwell,B.M.J., Cornell,C., and Turner, G.A., 1991, Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis, Br.J.Cancer 64:386–390.
Thompson,S., Record,C.O., and Turner,G.A., 1991, Studies of lotus-extracted haptoglobin in inflammatory bowel disease, Biochem.Soc.Trans. 19:264S
Thompson,S., Matta,K.L., and Turner,G.A., 1991, Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report, Clin.Chim.Acta 201:59–64.
Thompson,S., Dargan,E., and Turner,G.A., 1992, Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer, Cancer Letters 66:43–48.
Chambers.W., Thompson,S., Skillen,A.W., Record,C.O., and Turner,G.A., 1993 Abnormally-fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease, Clin.Chim.Acta 219:177–182.
Thompson,S., Dargan,E., Griffiths,I.D., Kelly,C.A., Turner,G.A., 1993 The glycosylation of haptoglobin in rheumatoid arthritis, Clin.Chim.Acta 220,107–114.
Mann,A.C., Record,C.O., Self,C.H., and Turner,G.A., 1994 Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease, Clin.Chim.Acta 227:69–78.
Dargan E., Thompson,S., Cantwell,B.M.J., Wilson,R.G., and Turner,G.A., 1994, Changes in the fucose content of haptoglobin in breast and ovarian cancer: association with disease progression, Glycosyl. &Dis. 1:37–43.
Katnik,I., Jadach,J., Krotkiewski,H., and Gerber,J., 1994, Investigating the glycosylation of normal and ovarian cancer haptoglobins using digoxigenin-labelled lectins, Glycosyl. &Dis. 2:97-104. 11.
Turner,G.A., Skillen,A.W., Buamah,P., Guthrie,D., Welsh,J., Harrison,J., and Kowalski,A., 1985 Relation between raised concentrations of fucose, sialic acid, and the acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers, J.Clin.Path.38:588–592.
Nilsson,B., Lowe,M., Osada,J., Ashwell,G., and Zopf,D., 1981, The carbohydrate structure of human haptoglobin 1-1, In: Yamakawa,T., et.al. eds. Glycoconjugates. Proc. 6th Int. Sym. Glyco. Tokyo: Japan Scientific Societies Press, 275–276.
Kaartinen V., and Mononen,I., 1988 Hemoglobin binding to deglycosylated haptoglobin, Biochim.Biophys.Acta 953:345–352.
Turner,G.A., 1992, N-glycosylation of serum proteins in disease and its investigation using lectins, Clin.Chim.Acta 208:149–171.
Anderson N.L., and Anderson N.G., 1979, Micoheterogeneity of serum transferrin, haptoglobin and α2HS glycoprotein examined by high resolution two-dimensional electrophoresis, Biochem.Biophys.Res.Comm. 88:258–265.
Katnik,I., 1984, Studies on haptoglobin binding to concanavalin A, Biochim.Biophy.Acta 790:8–14
Katnik,I., 1987, Factors influencing the reaction of haptoglobin with concanavalin A in affino-immunoelectrophoresis, Arch. Immunol. Therap. Exp. 35: 267–275.
Katnik,I., and Dobryszycka,W., 1992, Development of concanavalin A-enzyme immunosorbent assay for glycated haptoglobin using polyclonal and monoclonal antibodies, J.Immuno. 13: 145–
Thompson,S., Stappenbeck,R., Turner,G.A., 1989, A multiwell lectin-binding assay using lotus tetragonolobus for measuring different glycosylated forms of haptoglobin, Clin. Chim. Acta 180: 277–284.
Thompson S., Lathan J.A.E., and Turner G.A., 1987, A simple, reproducible and cheap batch method for the analysis of serum glycoproteins using Sepharose-coupled lectins and silver staining, Clin. Chim. Acta 167: 217–223.
Petryniak, J., and Goldstein, I.J., 1986, Immunochemical studies on the interaction between synthetic glycoconjugates and α-L-fucosyl binding lectins, Biochemistry 25: 2829–2838.
Debray, H., Decout, D., Strecker, G., Spik, G., and Montreuil J., 1981, Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycoproteins, Eur.J.Biochemistry 117, 41–55.
van Dijk, W., Turner, G.A., and Mackiewicz, A., 1994, Changes in glycosylation of acute-phase proteins in health and disease: occurrence, regulation and function, Glycosylation. &Dis. 1: 5–14.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Turner, G.A. (1995). Haptoglobin. In: Alavi, A., Axford, J.S. (eds) Glycoimmunology. Advances in Experimental Medicine and Biology, vol 376. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1885-3_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1885-3_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5768-1
Online ISBN: 978-1-4615-1885-3
eBook Packages: Springer Book Archive